UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): April 30, 2015

 

STAAR Surgical Company
(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of incorporation)		 0-11634
(Commission File Number)		 95-3797439
(I.R.S. Employer Identification No.)
     

1911 Walker Ave, Monrovia, California

(Address of principal executive offices)

   91016
(Zip Code)

 

 

Not Applicable

 

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

  Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 30, 2015, Robin Hughes, a named executive officer of STAAR Surgical Company (the “Company”), informed the Company of his decision to resign effective May 1, 2015. Mr. Hughes became an executive officer of the Company in 2007 and is its Vice President, Global Research and Development, and Clinical. Mr. Hughes will receive compensation consistent with the Executive Severance Agreement entered into with the Company in 2011, the terms of which were previously disclosed by the Company.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

April 30, 2015 By: /s/ Caren Mason
    Caren Mason
    President and Chief Executive Officer